Biocon Targets GLP-1s In MENA With Tabuk Tie-Up

Fresh Deal For Diabetes And Weight Products Builds On Existing Alliance Between Firms

 
• By Dave Wallace

Biocon has struck a deal that will see its GLP-1 diabetes and chronic weight management products commercialized in the Middle East region by partner Tabuk Pharmaceutical.

Magnifying glass over GLP-1 on blackboard
Biocon and Tabuk have teamed up on GLP-1s • Source: Shutterstock

More from Deals

More from Business